Skip to main content
Log in

Insulin and glucagon levels in living related liver transplantation: their interaction with the recovery of graft liver function

  • Original Article
  • Published:
Transplant International

Abstract

Insulin and glucagon have opposite effects on various hepatic functions, including energy metabolism, which is essential for hepatic viability. To evaluate the effects of insulin and glucagon on the recovery of graft liver function, changes in these levels were investigated in relation to arterial ketone body ratio (AKBR) during a 30-h period after graft liver reperfusion in 2i recipients of living related liver transplants. Insulin levels did not change significantly throughout this study, while glucagon levels decreased immediately after reperfusion, indicating a rapid degradation of glucagon by the graft liver. The insulin/glucagon (I/G) ratio increased after reperfusion concomitantly with AKBR. In addition, the I/G ratio was significantly correlated with AKBR after reperfusion. It is concluded that the increase in the I/G ratio was closely related to the recovery of graft liver function as reflected by the AKBR in living related liver transplantation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Atchison SR, Rettke SR, Fromme GA, Janossy TA, Kunkel SE, Williamson KR, Perkins JD, Rakela J (1989) Plasma glucose concentrations during liver transplantation. Mayo Clin Proc 64: 241–245

    Google Scholar 

  2. Mallett SV, Kang Y, Freeman JA, Aggarwal S, Gasior T, Fortunato FL (1987) Prognostic significance of blood glucose levels during liver transplantation. Anesthesiology 67: A313

  3. Mallett S, Virji MA, DeWolf AM, Kang YG, Aggarwal S, Freeman JA, Seifert R (1989) Hormonal control of glucose metabolism during liver transplantation. Transplant Proc 21: 3529

    Google Scholar 

  4. Marco J, Diego J, Villanueba ML, Diaz-Fierros M, Valverde I, Segovia JM (1973) Elevated plasma glucagon levels in cirrhosis of the liver. N Engl J Med 289: 1107–1111

    Google Scholar 

  5. Mori K, Ozawa K, Kiuchi T, Takada Y, Yamaguchi T, Sadamoto T, Shimahara Y, Kobayashi N, Yamaoka Y, Kumada K (1991) Insulinopenia as a risk factor in hepatectomy and its resolution by intraportal insulin administration. Am J Surg 162: 43–49

    Google Scholar 

  6. Ozawa K, Yamaoka Y, Nanbu H, Honjo I (1974) Insulin as the primary factor governing changes in mitochondrial metabolism leading to liver regeneration. Am J Surg 127: 669–675

    Google Scholar 

  7. Ozawa K, Aoyama H, Yasuda K, Shimahara Y, Nakatani T, Tanaka J, Yamamoto M, Kamiyama Y, Tobe T (1983) Metabolic abnormalities associated with postoperative organ failure. A redox theory. Arch Surg 118: 1245–1251

    Google Scholar 

  8. Starzl TE, Watanabe K, Porter KA, Putnam CW (1976) Effects of insulin, glucagon, and insulin/glucagon infusions on liver morphology and cell division after complete portocaval shunt in dogs. Lancet 1: 821–825

    Google Scholar 

  9. Takada Y, Yamaguchi T, Kiuchi T, Mori K, Shimahara Y, Kobayashi N, Yamaoka Y, Ozawa K (1991) Effect of glucagon on hepatic energy charge and arterial ketone body ratio in normal rabbits. Gastroenterology 100: 1041–1045

    Google Scholar 

  10. Takada Y, Ozaki N, Ringe B, Mori K, Gubernatis G, Oellerich M, Yamaguchi T, Kiuchi T, Shimahara Y, Yamaoka Y, Sakurai K, Ozawa K, Pichlmayr R (1992) Receiver operating characteristic (ROC) analysis of the ability of arterial ketone body ratio to predict graft outcome after liver transplantation — its sensitivity and specificity. Transpl Int 5: 23–26

    Google Scholar 

  11. Takada Y, Ozawa K, Yamaoka Y, Uemoto S, Tanaka A, Morimoto T, Honda K, Shimahara Y, Mori K, Inamoto T, Tanaka K (1993) Arterial ketone body ratio and glucose administration as an energy substrate in relation to changes in ketone body concentration after living-related liver transplantation in children. Transplantation 55: 1314–1319

    Google Scholar 

  12. Tanaka A, Kitai T, Iwata S, Hirao K, Tokuka A, Sato B, Yanabu N, Mori S, Inomoto T, Yamaoka Y, Tanaka K, Ozawa K, Chance B (1993) Delayed oxidation of intramitochondrial pyridine nucleotide oxidoreduction state as compared with tissue oxygenation in human liver transplantation. Biochim Biophys Acta 1182: 250–256

    Google Scholar 

  13. Tanaka K, Uemoto S, Tokunaga Y, Fujita S, Sano K, Nashizawa T, Sawada H, Shirahase I, Kim H-J, Yamaoka Y, Ozawa K (1993) Surgical techniques and innovations in living related liver transplantation. Ann Surg 217: 82–91

    Google Scholar 

  14. Uemoto S, Tanaka K, Honda K, Tokunaga Y, Sano K, Katoh H, Yamamoto E, Takada Y, Ozawa K (1993) Experience with FK506 in living-related liver transplantation. Transplantation 55: 288–292

    Google Scholar 

  15. Uno S, Itoh K, Kurono Y, Yamaoka Y, Kamiyama Y, Ozawa K (1987) A simple and sensitive assay for blood ketone bodies using highly purified 3-hydroxybutyrate dehydrogenase. Clin Chim Acta 168: 253–255

    Google Scholar 

  16. Yamada T, Yamamoto M, Ozawa K, Honjo I (1977) Insulin requirements for hepatic regeneration following hepatectomy. Ann Surg 185: 35–42

    Google Scholar 

  17. Yamaoka Y, Ozawa K, Tanaka A, Mori K, Morimoto T, Shimahara Y, Zaima M, Tanaka K, Kumada K (1991) New devices for harvesting a hepatic graft from a living donor. Transplantation 52: 157–160

    Google Scholar 

  18. Yamaoka Y, Washida M, Manaka D, Gubernatis G, Ringe R, Ozaki N, Yamaguchi T, Takada Y, Ollerich M, Ozawa K, Pichlmayr R (1993) Arterial ketone body ratio as a predictor of donor liver viability in human liver transplantation. Transplantation 55: 92–95

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

About this article

Cite this article

Ichimiya, M., Takada, Y., Shimahara, Y. et al. Insulin and glucagon levels in living related liver transplantation: their interaction with the recovery of graft liver function. Transpl Int 8, 165–168 (1995). https://doi.org/10.1007/BF00336531

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00336531

Key words

Navigation